Robert H Hyland

5PUBLICATIONS

28CO-AUTHORS

Nephrology and urologyMolecular medicineInfectious diseasesPharmacogenomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 10, 2026

Virologic insights from the phase 3 REDPINE trial: remdesivir in renally impaired and immunocompromised patients with COVID-19.

|Nov 12, 2025

Characterization of Drug-Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS-CoV-2, in Healthy Participants.

Jack Chang, Aryun Kim, Rita Humeniuk

|Jul 22, 2025

Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients With COVID-19 (BIRCH): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.

Anca Streinu-Cercel, Antonella Castagna, Shan-Chwen Chang

|Feb 13, 2025

Pharmacokinetics of SARS-CoV-2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment.

Sean Regan, Rita Humeniuk, Luzelena Caro

|Jun 28, 2024

Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants.

Olena Anoshchenko, Mazin Abdelghany, Amos Lichtman

Pageof 1

Frequent Collaborators

Luzelena Caro

Rita Humeniuk

Mazin Abdelghany

Lauren Rodriguez

Helen Winter

Yiannis Koullias

Olena Anoshchenko

Amos Lichtman

Jose Ramon Santos

Naveed A Shaik

Frequent Collaborators

Luzelena Caro

Rita Humeniuk

Mazin Abdelghany

Lauren Rodriguez